Literature DB >> 23483875

Hormonal and cytokine implications in the pathophysiology of osteoporosis occurring in chronic liver diseases.

Corina Lucaci1, Monica Acalovschi.   

Abstract

IN THE LAST YEARS THERE HAS BEEN AN INCREASED AWARENESS REGARDING THE ALTERATIONS OF BONE METABOLISM AS A COMMON COMPLICATION OF CHRONIC LIVER THAT OCCURS REGARDLESS OF THE ETIOLOGY: alcoholic, viral, autoimmune, whether or not associated with cholestasis.The aim of this paper was to summarize the current understanding of bone metabolism and to point out the new discoveries that have been made in this field.Bone density is maintained constant due to the equilibrium between bone formation bone resorbtion, under the control of hormonal and proinflammatory cytokines. The influence of sex hormones, parathyroid hormone, growth hormone, and insulin-like growth factor-1 and 2 on bone metabolism is discussed. The role of proinflammatory cytokines, CSF1-RANKL system, leptin and oncofetal fibronectin are also discussed.Although the physiological mechanism of bone metabolism has been established, when it comes to pathological conditions, the hormones and cytokines have different new roles, or are associated with other factors having different influences.

Entities:  

Year:  2012        PMID: 23483875      PMCID: PMC3593291     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  30 in total

1.  Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Gastroenterol Hepatol       Date:  2007-01-10       Impact factor: 11.382

Review 2.  Evaluation and management of osteoporosis in liver disease.

Authors:  J Eileen Hay; Maureen M J Guichelaar
Journal:  Clin Liver Dis       Date:  2005-11       Impact factor: 6.126

3.  Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.

Authors:  R S Weinstein; R L Jilka; A M Parfitt; S C Manolagas
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

4.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

5.  Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease.

Authors:  M P Duarte; M L Farias; H S Coelho; L M Mendonça; L M Stabnov; M do Carmo d Oliveira; R A Lamy; D S Oliveira
Journal:  J Gastroenterol Hepatol       Date:  2001-09       Impact factor: 4.029

6.  Osteodystrophy in patients with chronic hepatitis and liver cirrhosis.

Authors:  K Tsuneoka; Y Tameda; K Takase; T Nakano
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

7.  The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis C.

Authors:  T Piche; F Vandenbos; A Abakar-Mahamat; G Vanbiervliet; E M Barjoan; G Calle; J Giudicelli; B Ferrua; C Laffont; S Benzaken; A Tran
Journal:  J Viral Hepat       Date:  2004-01       Impact factor: 3.728

8.  Trabecular bone response to mechanical and parathyroid hormone stimulation: the role of mechanical microenvironment.

Authors:  Chi Hyun Kim; Erica Takai; Hua Zhou; Dietrich von Stechow; Ralph Müller; David W Dempster; X Edward Guo
Journal:  J Bone Miner Res       Date:  2003-12       Impact factor: 6.741

Review 9.  New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia.

Authors:  Ersi Voskaridou; Evangelos Terpos
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

Review 10.  Osteoimmunology--the hidden immune regulation of bone.

Authors:  J Caetano-Lopes; H Canhão; J E Fonseca
Journal:  Autoimmun Rev       Date:  2008-08-21       Impact factor: 9.754

View more
  3 in total

Review 1.  Osteoporosis across chronic liver disease.

Authors:  M Guarino; I Loperto; S Camera; V Cossiga; C Di Somma; A Colao; N Caporaso; F Morisco
Journal:  Osteoporos Int       Date:  2016-02-04       Impact factor: 4.507

2.  Associations of TNF-α and IL-6 polymorphisms with osteoporosis through joint effects and interactions with LEPR gene in Taiwan: Taichung Community Health Study for Elders (TCHS-E).

Authors:  Cheng-Chieh Lin; Tsai-Chung Li; Chiu-Shong Liu; Chuan-Wei Yang; Chih-Hsueh Lin; Jen-Hao Hsiao; Nai-Hsin Meng; Wen-Yuan Lin; Li-Na Liao; Chia-Ing Li; Fang-Yang Wu
Journal:  Mol Biol Rep       Date:  2016-07-11       Impact factor: 2.316

3.  Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series.

Authors:  Nan Chen; Jian-Bo Zhang; Qiujie Zhang; Yun-Peng Zhao; Li-Yan Li; Li-Wei Liu; Fei Yu; Xin Yu; Tao Peng; Kuan-Xiao Tang
Journal:  BMC Pharmacol Toxicol       Date:  2018-05-16       Impact factor: 2.483

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.